The traditional cadence of healthcare, marked by periodic check-ups and reactive interventions, is being fundamentally rewritten by a continuous and intelligent stream of personal health data. This profound transformation is being driven by connected medical devices, which are seamlessly
In a significant move to preserve continuity of care for millions of Americans, federal health and drug enforcement agencies have once again prolonged the flexible telehealth prescribing rules for controlled substances that originated during the public health emergency. This joint action by the
In a landmark decision that promises to reshape the landscape of cancer treatment technology in India, the Central Drugs Standard Control Organization (CDSCO) has brought much-needed clarity to a previously ambiguous regulatory environment by finalizing a comprehensive risk-classification list for
The audacious plan to dismantle and rebuild foundational elements of the American healthcare system was unveiled not from a traditional policy forum, but from the high-powered stage of the J.P. Morgan Healthcare Conference, signaling a seismic shift in how Washington intends to engage with the
Health systems across many low- and middle-income countries are straining under the weight of persistent challenges, including critical workforce shortages, fragmented service delivery, and inadequate data systems that limit access to care and perpetuate inequities in health outcomes. These issues
The biopharmaceutical sector is holding its collective breath as a series of high-stakes regulatory decisions promises to redraw competitive maps and dictate market leadership for years to come. The first quarter is not just another period of clinical trial readouts and earnings reports; it
